Cetera Advisor Networks
HQL icon

Cetera Advisor Networks’s abrdn Life Sciences Investors HQL Stock Holding History

Cetera Advisor Networks’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-13,467
Closed -$259K – 2121
2021
Q4 		$259K Buy
+13,467
New +$271K ﹤0.01% 1703
2020
Q3 		– Sell
-4,775
Closed -$86K – 2007
2020
Q2 		$86K Buy
+4,775
New +$81.9K ﹤0.01% 1602

Other funds holding HQL

Needham Investment Management
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Flagship Harbor Advisors
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
Advisors Asset Management
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Atlantic Union Bankshares
Atlantic Union Bankshares Glen Allen, Virginia $5.99B AUM 23.66% 1-Year Est. Return
180 Wealth Advisors
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Cetera Advisor Networks's HQL Position: Q1 2022 in Review

Cetera Advisor Networks sold out of abrdn Life Sciences Investors (HQL) in Q1 2022, closing a stake of 13,467 shares — an estimated $259K sold.

Cetera Advisor Networks first reported a position in HQL in Q2 2020 and held it in 2 quarters. The position peaked at $259K in Q4 2021. 66 funds tracked by Wall St. Rank hold HQL as of Q1 2022.

  • Cetera Advisor Networks reported no remaining abrdn Life Sciences Investors position as of Q1 2022 after selling out during the quarter.
  • Cetera Advisor Networks sold 13,467 abrdn Life Sciences Investors shares in Q1 2022, an estimated $259K.
  • Cetera Advisor Networks first reported a position in abrdn Life Sciences Investors in Q2 2020 and held it in 2 quarters.
  • Cetera Advisor Networks's abrdn Life Sciences Investors position peaked at $259K in Q4 2021.
  • 66 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2022.

Based on Cetera Advisor Networks's 13F filing for Q1 2022, filed 12 May 2022.